What is going on with bluebird bio?
What is going on with bluebird bio?
Bluebird bio will cut 30% of its workforce in the hopes of extending its cash runway into the first half of 2023, the company revealed Tuesday. As of Jan. 31, the Massachusetts biotech counted 518 full-time employees, according to its annual report.
Who is the CEO of bluebird bio?
Andrew Obenshain (Nov 2021–)bluebird bio / CEO
Is bluebird bio a public company?
CAMBRIDGE, Mass. –(BUSINESS WIRE)–May 18, 2020– bluebird bio, Inc. (Nasdaq: BLUE) today announced the pricing of an underwritten public offering of 9,090,910 shares of its common stock at a public offering price of $55.00 per share, before underwriting discounts.
How many employees does bluebird bio have?
We are 500+ employees who care deeply and challenge convention to help the people who need us. We are working toward four potential product approvals by 2022 and a pipeline ready to tackle a range of severe diseases.
Where is bluebird bio based?
Cambridge, Massachusetts
bluebird bio, Inc., based in Cambridge, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders and cancer. bluebird bio, Inc. Cambridge, Massachusetts, U.S.
Is Bluebird Bio a good stock to buy?
bluebird bio has received a consensus rating of Hold. The company’s average rating score is 2.07, and is based on 1 buy rating, 11 hold ratings, and 2 sell ratings.
Who owns Bluebird Pharma?
bluebird bio
| Type | Public company |
|---|---|
| Founders | Philippe Leboulch and Irving London |
| Headquarters | Cambridge, Massachusetts, U.S. |
| Key people | Nick Leschly, President & CEO Chip Baird, CFO |
| Products | Zynteglo, Skysona |
Is Bluebird an American company?
The Blue Bird Corporation (originally known as the Blue Bird Body Company) is an American bus manufacturer headquartered in Fort Valley, Georgia.
Who owns Bluebird biotech?
Is bluebird bio a good company to work for?
Is bluebird bio a good company to work for? bluebird bio has an overall rating of 3.5 out of 5, based on over 187 reviews left anonymously by employees. 62% of employees would recommend working at bluebird bio to a friend and 37% have a positive outlook for the business.
Is Bluebird Bio a good company to work for?
Will Bluebird stock go up?
bluebird bio Inc (NASDAQ:BLUE) The 8 analysts offering 12-month price forecasts for bluebird bio Inc have a median target of 8.00, with a high estimate of 14.00 and a low estimate of 2.00. The median estimate represents a +109.97% increase from the last price of 3.81.
What is Bluebird Bio doing for curative gene therapies?
corporate profile bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days.
What is Bluebird doing now?
Today, bluebird continues to forge new paths, combining our real-world experience with a deep commitment to patient communities and a people-centric culture that attracts and grows a diverse flock of dedicated birds. stock quote NASDAQ: (common stock)
What is Bluebird doing for sickle cell disease?
With a dedicated focus on severe genetic diseases, bluebird has industry-leading clinical programs for sickle cell disease, β-thalassemia and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases.
Where can I find Bluebird in Greece?
bluebird bio Greece Single Member L.L.C. 166A, Kifissias Avenue & 2 Sofokleous Str. GR-151 26 Maroussi, Athens Greece +30 210 7264118. bluebird bio (Italy) S.r.l. Viale Abruzzi 94 Regus Center Loreto I-20131 Milan. bluebird bio (Netherlands) B.V. WTC Utrecht Stadsplateau 7 7th floor The Office Operators
